14
Molecular docking and dynamics simulation of piperine as a potential inhibitor of class C beta-lactamase
14
10.58342/ajid/ghalibuni.v.1.I.1.6
Molecular docking and dynamics simulation of piperine as a potential inhibitor of class C beta-lactamase
<p><strong>Background: </strong>Antimicrobial resistance is a major concern of human being through the decades which are the cause of hundred thousand of death. β -lactamases secretion by bacteria is one of main resistant mechanism enzymes bacteria to fight antibiotics. Multiple investigation has performed to inhibit the β-lactamase enzyme activity which is one of the important ways to reduce microbial drug resistance and increase the effectiveness of antibiotics.</p>
<p><strong>Methods: </strong>Molecular docking was performed to determine the binding pose and binding energy of class C beta lactamase with piperine using Autodock 4.2.2 software. Molecular dynamic simulation was carried out for enzyme utilizing GROMACS 2019.6 program applying AMBER99SB force field.</p>
<p><strong>Results: </strong>Molecular docking results and interaction analysis of molecular dynamics simulations showed favorable hydrogen bonds and van der Waals interactions of Piperine with AmpC. The results of this paper may provide a new perspective to solve the problem of drug resistance caused by bacteria and help to design new beta-lactamase inhibitors in the future.</p>
<p><strong>Conclusion: </strong>By using the valuable techniques of molecular docking and molecular dynamics simulation, this paper suggests that Piperine, which is the main component of black pepper and has significant medicinal effects, can be used to inhibit AmpC β -lactamase class C enzyme.</p>
https://creativecommons.org/licenses/by/4.0
Afghanistan Journal of Infectious Diseases
2023
Molecular docking
Molecular dynamics simulation
Piperine, β-Lactamase Class C enzyme
Hamza
Mansoori
Ghalib University
AF
sayedhussain.mosawi@ghalib.edu.af
https://orcid.org/0009-0006-2933-1374
<p>Medical Sciences Research Center, Ghalib University, Kabul, Afghanistan.</p>
Sayed Hussain
Mosawi
Ghalib University
AF
sayedhussain.mosawi@ghalib.edu.af
https://orcid.org/0000-0001-6516-9542
<p>Medical Sciences Research Center, Ghalib University, Kabul, Afghanistan.</p>
Abdul Musawer
Bayan
Ghalib University
AF
sayedhussain.mosawi@ghalib.edu.af
https://orcid.org/0009-0004-1537-677X
<p>Medical Sciences Research Center, Ghalib University, Kabul, Afghanistan.</p>
10
PDF
0
Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Bulletin of the World Health Organization. 2001; 79:780-90.
Scholar EM, Scholar EM, Pratt WB. The antimicrobial drugs: Oxford University Press, USA; 2000.
Giwercman B, Jensen ET, Høiby N, Kharazmi A, Costerton JW. Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrobial agents and chemotherapy. 1991; 35(5):1008-10.
González-Bello Cn, Rodríguez D, Pernas M, Rodriguez A, Colchón E. β-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs. Journal of medicinal chemistry. 2019;63(5):1859-81.
Hall BG, Barlow M. Revised Ambler classification of β-lactamases. Journal of Antimicrobial Chemotherapy. 2005; 55(6):1050-1.
Donowitz GR, Mandell GL. Beta-lactam antibiotics. New England Journal of Medicine. 1988; 318(7):419-26.
Webb GF, D'Agata EM, Magal P, Ruan S. A model of antibiotic-resistant bacterial epidemics in hospitals. Proceedings of the National Academy of Sciences. 2005; 102(37):13343-8.
Ng TM, Khong WX, Harris PN, De PP, Chow A, Tambyah PA, et al. Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. PloS one. 2016; 11(4):e0153696.
Rafailidis PI, Ioannidou EN, Falagas ME. Ampicillin/sulbactam. Drugs. 2007;67(13):1829-49.
Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. Journal of natural products. 2016; 79(3):629-61.
Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nature reviews Drug discovery. 2005;4 (3):206-20.
Haq IU, Imran M, Nadeem M, Tufail T, Gondal TA, Mubarak MS. Piperine: A review of its biological effects. Phytotherapy Research. 2021;35(2):680-700.
Okwute SK, Egharevba HO. Piperine-type amides: review of the chemical and biological characteristics. International Journal of Chemistry. 2013;5(3):99.
Li Y, Gao L, Shi H, Feng S, Tian X, Kong L, et al. Piperine inhibits the transformation of endothelial cells into fibroblasts. Zhonghua xin xue Guan Bing za zhi. 2019; 47(7):554-60.
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic acids research. 2000; 28(1):235-42.
Sterling T, Irwin JJ. ZINC 15–ligand discovery for everyone. Journal of chemical information and modeling. 2015; 55(11):2324-37.
Chen Y, Shoichet BK. Molecular docking and ligand specificity in fragment-based inhibitor discovery. Nature chemical biology. 2009; 5(5):358-64.
Olsen L, Pettersson I, Hemmingsen L, Adolph H-W, Jørgensen FS. Docking and scoring of metallo-β-lactamases inhibitors. Journal of computer-aided molecular design. 2004; 18(4):287-302.
Sousa da Silva AW, Vranken WF. ACPYPE-Antechamber python parser interface. BMC research notes. 2012; 5:1-8.
Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: fast, flexible, and free. Journal of computational chemistry. 2005; 26 (16):1701-18.
1
1
2023
First Volume, First issue, january 2023
27-32